|
1
|
Pharmacology of cardiac potassium channels.
|
Cardiovasc Res
|
2004
|
1.90
|
|
2
|
Interaction of angiotensin II with the angiotensin type 2 receptor inhibits the cardiac transient outward potassium current.
|
Cardiovasc Res
|
2004
|
1.46
|
|
3
|
Heberprot-P: a novel product for treating advanced diabetic foot ulcer.
|
MEDICC Rev
|
2013
|
1.08
|
|
4
|
Safety and preliminary efficacy data of a novel casein kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies.
|
BMC Cancer
|
2009
|
1.02
|
|
5
|
Immunomodulatory effects of diclofenac in leukocytes through the targeting of Kv1.3 voltage-dependent potassium channels.
|
Biochem Pharmacol
|
2010
|
0.99
|
|
6
|
Assembly with the Kvbeta1.3 subunit modulates drug block of hKv1.5 channels.
|
Mol Pharmacol
|
2002
|
0.99
|
|
7
|
CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo.
|
Mol Cell Biochem
|
2008
|
0.99
|
|
8
|
Spironolactone and its main metabolite, canrenoic acid, block human ether-a-go-go-related gene channels.
|
Circulation
|
2003
|
0.97
|
|
9
|
Cell cycle-dependent expression of Kv1.5 is involved in myoblast proliferation.
|
Biochim Biophys Acta
|
2008
|
0.96
|
|
10
|
Kvbeta1.3 reduces the degree of stereoselective bupivacaine block of Kv1.5 channels.
|
Anesthesiology
|
2007
|
0.95
|
|
11
|
CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research.
|
Mol Cell Biochem
|
2011
|
0.95
|
|
12
|
Celecoxib blocks cardiac Kv1.5, Kv4.3 and Kv7.1 (KCNQ1) channels: effects on cardiac action potentials.
|
J Mol Cell Cardiol
|
2010
|
0.93
|
|
13
|
{Omega}-3 and {omega}-6 polyunsaturated fatty acids block HERG channels.
|
Am J Physiol Cell Physiol
|
2005
|
0.91
|
|
14
|
Effects of propafenone and its main metabolite, 5-hydroxypropafenone, on HERG channels.
|
Cardiovasc Res
|
2003
|
0.90
|
|
15
|
Immunomodulation of voltage-dependent K+ channels in macrophages: molecular and biophysical consequences.
|
J Gen Physiol
|
2010
|
0.89
|
|
16
|
Irvalec inserts into the plasma membrane causing rapid loss of integrity and necrotic cell death in tumor cells.
|
PLoS One
|
2011
|
0.88
|
|
17
|
Effects of n-3 Polyunsaturated Fatty Acids on Cardiac Ion Channels.
|
Front Physiol
|
2012
|
0.87
|
|
18
|
Protein kinase C (PKC) activity regulates functional effects of Kvβ1.3 subunit on KV1.5 channels: identification of a cardiac Kv1.5 channelosome.
|
J Biol Chem
|
2012
|
0.86
|
|
19
|
Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization.
|
J Pharmacol Exp Ther
|
2003
|
0.85
|
|
20
|
Modulation of the atrial specific Kv1.5 channel by the n-3 polyunsaturated fatty acid, alpha-linolenic acid.
|
J Mol Cell Cardiol
|
2007
|
0.85
|
|
21
|
Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults.
|
Hum Vaccin
|
2011
|
0.83
|
|
22
|
Putative binding sites for benzocaine on a human cardiac cloned channel (Kv1.5).
|
Cardiovasc Res
|
2002
|
0.83
|
|
23
|
Ceramide inhibits Kv currents and contributes to TP-receptor-induced vasoconstriction in rat and human pulmonary arteries.
|
Am J Physiol Cell Physiol
|
2011
|
0.81
|
|
24
|
Polyunsaturated Fatty acids modify the gating of kv channels.
|
Front Pharmacol
|
2012
|
0.81
|
|
25
|
Safety and Immunogenicity of a Human Papillomavirus Peptide Vaccine (CIGB-228) in Women with High-Grade Cervical Intraepithelial Neoplasia: First-in-Human, Proof-of-Concept Trial.
|
ISRN Obstet Gynecol
|
2011
|
0.81
|
|
26
|
Modulation of voltage-dependent and inward rectifier potassium channels by 15-epi-lipoxin-A4 in activated murine macrophages: implications in innate immunity.
|
J Immunol
|
2013
|
0.81
|
|
27
|
Differential regulation of Na(v)beta subunits during myogenesis.
|
Biochem Biophys Res Commun
|
2008
|
0.80
|
|
28
|
Pharmacological electrical remodelling in human atria induced by chronic beta-blockade.
|
Cardiovasc Res
|
2003
|
0.79
|
|
29
|
Effects of levobupivacaine, ropivacaine and bupivacaine on HERG channels: stereoselective bupivacaine block.
|
Br J Pharmacol
|
2002
|
0.79
|
|
30
|
The induction of NOS2 expression by the hybrid cecropin A-melittin antibiotic peptide CA(1-8)M(1-18) in the monocytic line RAW 264.7 is triggered by a temporary and reversible plasma membrane permeation.
|
Biochim Biophys Acta
|
2005
|
0.79
|
|
31
|
Pharmacokinetic comparison of two recombinant human granulocyte colony-stimulating factor after subcutaneous administration in rabbits.
|
Eur J Pharm Biopharm
|
2005
|
0.79
|
|
32
|
Voltage-dependent Na+ channel phenotype changes in myoblasts. Consequences for cardiac repair.
|
Cardiovasc Res
|
2007
|
0.78
|
|
33
|
Activating transcription factor 6 derepression mediates neuroprotection in Huntington disease.
|
J Clin Invest
|
2016
|
0.77
|
|
34
|
Kv1.5-Kv beta interactions: molecular determinants and pharmacological consequences.
|
Mini Rev Med Chem
|
2010
|
0.77
|
|
35
|
Female gender: risk factor for congenital long QT-related arrhythmias.
|
Cardiovasc Res
|
2012
|
0.75
|
|
36
|
Integrated pharmacokinetic-pharmacodynamic modeling and allometric scaling for optimizing the dosage regimen of the monoclonal ior EGF/r3 antibody.
|
Eur J Pharm Sci
|
2004
|
0.75
|
|
37
|
Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine male healthy volunteers.
|
Eur J Pharm Sci
|
2012
|
0.75
|